401 related articles for article (PubMed ID: 24378231)
41. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
42. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
43. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
[TBL] [Abstract][Full Text] [Related]
45. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
46. Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.
Rick F; Niyibizi AA; Shroufi A; Onami K; Steele SJ; Kuleile M; Muleya I; Chiller T; Walker T; Van Cutsem G
PLoS One; 2017; 12(9):e0183656. PubMed ID: 28877182
[TBL] [Abstract][Full Text] [Related]
47. Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV-Related Cryptococcosis.
Jitmuang A; Panackal AA; Williamson PR; Bennett JE; Dekker JP; Zelazny AM
J Clin Microbiol; 2016 Feb; 54(2):460-3. PubMed ID: 26607986
[TBL] [Abstract][Full Text] [Related]
48. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
49. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis.
Asawavichienjinda T; Sitthi-Amorn C; Tanyanont V
J Med Assoc Thai; 1999 Jan; 82(1):65-71. PubMed ID: 10087741
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
[TBL] [Abstract][Full Text] [Related]
51. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study.
Paccoud O; Shuping L; Mashau R; Greene G; Quan V; Meiring S; Govender NP;
Clin Microbiol Infect; 2023 Aug; 29(8):1063-1069. PubMed ID: 37086780
[TBL] [Abstract][Full Text] [Related]
52. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.
Manabe YC; Nonyane BA; Nakiyingi L; Mbabazi O; Lubega G; Shah M; Moulton LH; Joloba M; Ellner J; Dorman SE
PLoS One; 2014; 9(7):e101459. PubMed ID: 25000489
[TBL] [Abstract][Full Text] [Related]
53. Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda.
Levin AE; Bangdiwala AS; Nalintya E; Kagimu E; Kasibante J; Rutakingirwa MK; Mpoza E; Jjunju S; Nuwagira E; Naluyima R; Kirumira P; Hou C; Ssebambulidde K; Musubire AK; Williams DA; Abassi M; Muzoora C; Hullsiek KH; Rajasingham R; Meya DB; Boulware DR; Skipper CP
Clin Infect Dis; 2023 Feb; 76(3):e759-e765. PubMed ID: 35859045
[TBL] [Abstract][Full Text] [Related]
54. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
Jarvis JN; Harrison TS; Lawn SD; Meintjes G; Wood R; Cleary S
PLoS One; 2013; 8(7):e69288. PubMed ID: 23894442
[TBL] [Abstract][Full Text] [Related]
55. Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results.
Blasich NP; Coetzee LM; Sriruttan C; DeSanto D; Greene GS; Glencross DK; Govender NP
Lab Med; 2022 Nov; 53(6):614-618. PubMed ID: 35660925
[TBL] [Abstract][Full Text] [Related]
56. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.
Ssebambulidde K; Bangdiwala AS; Kwizera R; Kandole TK; Tugume L; Kiggundu R; Mpoza E; Nuwagira E; Williams DA; Lofgren SM; Abassi M; Musubire AK; Cresswell FV; Rhein J; Muzoora C; Hullsiek KH; Boulware DR; Meya DB;
Clin Infect Dis; 2019 May; 68(12):2094-2098. PubMed ID: 30256903
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.
McKenney J; Smith RM; Chiller TM; Detels R; French A; Margolick J; Klausner JD;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(27):585-7. PubMed ID: 25006824
[TBL] [Abstract][Full Text] [Related]
58. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H
HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440
[TBL] [Abstract][Full Text] [Related]
59. The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time.
Tang MW; Clemons KV; Katzenstein DA; Stevens DA
Crit Rev Microbiol; 2016 Aug; 42(4):634-42. PubMed ID: 25612826
[TBL] [Abstract][Full Text] [Related]
60. A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda.
Lofgren SM; Nalintya E; Meya DB; Boulware DR; Rajasingham R
Medicine (Baltimore); 2018 Aug; 97(31):e11722. PubMed ID: 30075580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
